Immunization with HSV-1 antigen rapidly protects against HSV-1-induced encephalitis and is IFN-γ independent

Journal of Interferon and Cytokine Research

Volumn 18, Issue 3, 1998, Pages 151-158

  Halford, William P ^a   Veress, Livia A ^a   Gebhardt, Bryan M ^a   Carr, Daniel J J ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Microbiology and Immunology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INACTIVATED VIRUS VACCINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIVE VACCINE; MESSENGER RNA; VIRUS ANTIGEN;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INFECTION; HELPER CELL; HERPES SIMPLEX VIRUS 1; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIGEMINUS GANGLION; VIRUS ATTENUATION; VIRUS ENCEPHALITIS; VIRUS INFECTION;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1;

EID: 0031968491     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.151     Document Type: Article

References (36)

1. OAKES, J.E., DAVIS, W.B., TAYLOR, J.A., and WEPPNER, W.A. (1980). Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice. Infect. Immun. 29, 642-649.
2. MORAHAN, P.S., THOMSON, T.A., KOHL, S., and MURRAY, B.K. (1981). Immune responses to labial infection and BALB/c mice with herpes simplex virus type 1. Infect. Immun. 32, 180-187.
3. COOK, M.L., and STEVENS, J.G. (1973). Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect. Immun. 7, 272-278.
4. SCHRODER, C.H., KUMEL, G., GLORIOSO, J., KIRCHNER, H., and KAERNER, H.C. (1983). Neuropathogenicity of herpes simplex virus in mice: protection against lethal encephalitis by co-infection with a non-encephalitogenic strain. J. Gen. Virol. 64, 1973-1982.
5. HILL, T.J., YIRRELL, D.L., and BLYTH, W.A. (1986). Infection of the adrenal gland as a route to the central nervous system after viraemia with herpes simplex virus in the mouse. J. Gen. Virol. 67, 309-320.
6. WILDY, P. (1967). The progression of herpes simplex virus to the central nervous system of the mouse. J. Hyg. 65, 173-192.
7. KNOTTS, F.B., COOK, M.L., and STEVENS, J.G. (1974). Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation. J. Infect. Dis. 130, 16-27.
8. MCKENDALL, R.R., KLASSEN, T., and BARINGER, J.R. (1979). Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infect. Immun. 23, 305-311.
9. OAKES, J.E., and LAUSCH, R.N. (1984). Monoclonal antibodies suppress replication of herpes simplex virus type 1 in the trigeminal ganglion. J. Virol. 51, 656-661.
10. ERTURK, H., ZAWATSKY, R., GOLDBACH, A., SCHRODER, C.H., WEYAND, C., HAMMERLING, G.J., and KIRCHNER, H. (1992). Acute and latent infection of mice immunized with HSV-1 ISCOM vaccine. Arch. Virol. 125, 87-101.
11. SHIMELD, C., HILL, T., BLYTH, B., and EASTY, D. (1989). An improved model of recurrent herpetic disease in mice. Curr. Eye Res. 8, 1193-1205.
12. MORRISON, L.A., and KNIPE, D.M. (1994). Immunization with replication defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. J. Virol. 68, 689-696.
13. LEWANDOWSKI, G.A., LO, D., and BLOOM, F.E. (1993). Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response. Proc. Natl. Acad. Sci. USA 90, 2005-2008.
14. PEREIRA, R.A., TSCHARKE, D.C., and SIMMONS, A. (1994). Upregulation of class I major histocompatibility complex gene expression in primary sensory neurons, satellite cells, and Schwann cells of mice in response to acute but not latent herpes simplex virus infection in vivo. J. Exp. Med. 180, 841-850.
15. ENGLER, H., ZAWATZKY, R., GOLDBACH, A., SCHRODER, C.H., WEYAND, C., HAMMERLING, G.J., and KIRCHNER, H. (1981). Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate. J. Gen. Virol. 55, 25-30.
16. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68, 825-833.
17. BONNEAU, R.H., and JENNINGS, S.R. (1989). Modulation of acute and latent herpes simplex virus infection in C57B1/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J. Virol. 63, 1480-1484.
18. SIMMONS, A., and TSCHARKE, D.C. (1992). Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175, 1337-1344.
19. TUMPEY, T.M., CHEN, S.-H., OAKES, J.E., and LAUSCH, R.N. (1996). Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70, 898-904.
20. MITTNACHT, S., STRAUB, P., KIRCHNER, H., and JACOBSEN, H. (1988). Interferon treatment inhibits onset of herpes simplex virus immediately-early transcription. Virology 164, 201-210.
21. FEDUCHI, E., ALONSO, M.A., and CARRASCO, L. (1989). Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63, 1354-1359.
22. CHEN, S.-H., OAKES, J.E., and LAUSCH, R.E. (1993). Synergistic anti-HS V effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction. Antiviral Res. 22, 15-29.
23. HALFORD, W.P., VERESS, L.A., GEBHARDT, B.M., and CARR, D.J.J. (1997). Innate and acquired immunity to herpes simplex virus type 1. Virology 236, 328-337.
24. STEVENS, J.G., and COOK, M.L. (1971). Latent herpes simplex virus in spinal ganglia of mice. Science 173, 843-845.
25. HALFORD, W.P., GEBHARDT, B.M., and CARR, D.J.J. (1996). Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157, 3542-3549.
26. KANANGAT, S., THOMAS, J., GANGAPPA, S., BABU, J.S., and ROUSE, B.T. (1996). Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. J. Immunol. 156, 1110-1116.
27. ISHIKAWA, R., and BIRON, C.A. (1993). IFN induction and associated changes in splenic leukocyte distribution. J. Immunol. 150, 3713-3727.
28. PERNG, G.-C., HOMAYON, G., SLANINA, S.M., NESBURN, A.B., and WECHSLER, S.L. (1996). High dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no comeal disease or neurovirulence yet results in wild type levels of spontaneous reactivation. J. Virol. 70, 2883-2893.
29. NAGAFUCHI, H.O., MORI, R., and TANIGUCHI, T. (1979). Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice. J. Gen. Virol. 44, 715-723.
30. IGIETSEME, J.U., STREILEIN, J.W., MIRANDA, F., FEINERMAN, S.J., and ATHERTON, S.S. (1991). Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes. J. Virol. 65, 763-768.
31. HENDRICKS, R.L., WEBER, P.C., TAYLOR, J.L., KOUMBIS, A., TUMPEY, T.M., and GLORIOSO, J.C. (1991). Endogenously produced interferon α protects mice from herpes simplex virus type 1 comeal disease. J. Gen. Virol. 72, 1601-1610.
32. SHIMELD, C., WHITELAND, J.L., NICHOLLS, S.M., GRINFELD, E., EASTY, D.L., GAO, H., and HILL, T.J. (1995). Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61, 7-16.
33. SHIMELD, C., WHITELAND, J.L., WILLIAMS, N.A., EASTY, D.L., and HILL, T.J. (1996). Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and immune cell infiltration. J. Gen. Virol. 77, 2583-2590.
34. + cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1. J. Virol. 71, 3534-3544.
35. TRINCHIERI, G. (1995). Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
36. CARR, J.A., ROGERSON, J., MULQUEEN, M.J., ROBERTS, N.A., and BOOTH, R.F.G. (1997). Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections. J. Virol. 71, 7799-7803.